Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M90.8Revenue (TTM) $M--Net Margin (%)--Altman Z-Score2.2
Enterprise Value $M81.5EPS (TTM) $-0.3Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.710-y EBITDA Growth Rate %--Quick Ratio6.1Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-28.3Current Ratio6.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-39.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-43.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M95.6ROIC % (ttm)-60.4Gross Margin Increase y-yN

Gurus Latest Trades with BLRX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BLRX is held by these investors:



BLRX: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about BLRX:

    News about BLRX:

    Articles On GuruFocus.com
    BioLineRx Announces Initiation of Phase 1b/2 Trial of BL-8040 in Pancreatic Cancer Under Immunothera Jul 10 2017 
    BioLineRx Reports Regulatory Submissions of Three Phase 1b Trials for BL-8040 in Combination With At Jun 01 2017 
    BioLineRx Announces Regulatory Submission for Phase 1b Trial of BL-8040 in Combination with Atezoliz May 22 2017 
    BioLineRx to Report First Quarter 2017 Results on May 25, 2017 May 16 2017 
    BioLineRx to Initiate Phase 3 Study with BL-8040 as Novel Stem Cell Mobilization Treatment Following May 03 2017 
    BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares Apr 05 2017 
    BioLineRx Announces Underwritten Public Offering of its American Depositary Shares Mar 31 2017 
    BioLineRx Prices $25 Million Underwritten Public Offering Mar 31 2017 
    Analysts Positive on BioLineRx Ltd. Following Ph2 Testing Expansion for AML May 05 2015 
    Roth Capital Weighs In On 5 Biotech Stocks to Watch Apr 05 2015 

    More From Other Websites
    BioLine Rx (BLRX) Catches Eye: Stock Adds 5.2% in Session Jul 21 2017
    BioLineRx/Roche Scan BL-8040-Tecentriq for Pancreatic Cancer Jul 11 2017
    BioLineRx Announces Initiation of Phase 1b/2 Trial of BL-8040 in Pancreatic Cancer Under... Jul 10 2017
    Top 10 Penny Stocks To Buy in 2017 Jun 29 2017
    Corporate News Blog - Concordia Announces Review of Strategic Alternatives; Views Itself on the... Jun 23 2017
    BioLineRx Reports Regulatory Submissions of Three Phase 1b Trials for BL-8040 in Combination With... Jun 01 2017
    Investor Network: Bioline RX Ltd Sponsored ADR to Host Earnings Call May 25 2017
    BioLineRx Reports First Quarter 2017 Financial Results May 25 2017
    BioLineRx Makes Regulatory Submission for Trial of BL-8040 May 23 2017
    BioLineRx Announces Regulatory Submission for Phase 1b Trial of BL-8040 in Combination with... May 22 2017
    [$$] BiolineRX Shares Could Triple May 19 2017
    BioLineRx to Report First Quarter 2017 Results on May 25, 2017 May 16 2017
    BioLineRx to Initiate Phase 3 Study with BL-8040 as Novel Stem Cell Mobilization Treatment Following... May 03 2017
    [$$] Four Small Biotechs See Bullish April Stock Buys May 03 2017
    BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares Apr 05 2017
    Today's Research Reports on Biotech Stocks to Watch: Bioline RX and Cara Therapeutics Apr 03 2017
    BioLineRx Prices $25 Million Underwritten Public Offering Mar 31 2017
    BioLineRx Announces Underwritten Public Offering of its American Depositary Shares Mar 30 2017
    BioLineRx's AGI-134 to be Presented at AACR 2017 Mar 27 2017
    BioLineRx Reports Year End 2016 Financial Results Mar 23 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat

    {{numOfNotice}}